I don’t really understand why people assume the stock would skyrocket just because it’s announced that Akida is being used in the Switch 2.
Looking at the numbers alone …depending on the licensing agreement… BrainChip would only get a small cut per unit sold. That revenue would then have to be translated into actual earnings or reported sales before it can meaningfully impact the share price.
Realistically, I could see the stock going back up to around $0.50–$0.70 AUD, maybe hitting $2–3 AUD temporarily if FOMO kicks in.
It would definitely be great for the industry as a whole… we’d gain more recognition and legitimacy, and the foundation would finally feel more solid.
But that would also put much more pressure on the team to deliver.
If nothing else follows within a year, the market will respond .. harshly.
Still… it would be a start.
Looking at the numbers alone …depending on the licensing agreement… BrainChip would only get a small cut per unit sold. That revenue would then have to be translated into actual earnings or reported sales before it can meaningfully impact the share price.
Realistically, I could see the stock going back up to around $0.50–$0.70 AUD, maybe hitting $2–3 AUD temporarily if FOMO kicks in.
It would definitely be great for the industry as a whole… we’d gain more recognition and legitimacy, and the foundation would finally feel more solid.
But that would also put much more pressure on the team to deliver.
If nothing else follows within a year, the market will respond .. harshly.
Still… it would be a start.